• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌患者的性别相关基因改变。

Genetic alterations in gastric cancer patients according to sex.

机构信息

Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.

School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

Aging (Albany NY). 2020 Dec 3;13(1):376-388. doi: 10.18632/aging.202142.

DOI:10.18632/aging.202142
PMID:33288737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7835020/
Abstract

To date, few reports have investigated the genetic alterations and clinicopathological features in gastric cancer (GC) according to sex. In total, 2673 GC patients receiving curative surgery were enrolled. Among the 2673 GC patients, 1979 (74.0%) patients were male. After propensity-score matching, 846 patients were enrolled for the analysis, including 423 males and 423 females. There was no significant difference in the clinicopathological features between the sexes. Regarding the initial recurrence pattern, the males were more likely to develop tumor recurrence and liver metastasis than the females, especially in stage III GC. Regarding the molecular analysis, the males had higher expression than the females, especially in stage III GC. In addition, the patients aged ≥ 65 years had higher expression than the patients younger than 65 years. The multivariate analysis demonstrated that sex was among the independent prognostic factors affecting overall survival (OS) and disease-free survival (DFS). Among the patients with liver metastases, expression was more common among the aged male patients. The males were associated with more tumor recurrence and higher expression than the females, especially in stage III GC. For GC patients with liver metastases, testing is recommended, especially among aged male patients.

摘要

迄今为止,鲜有研究根据性别调查胃癌(GC)的遗传改变和临床病理特征。共纳入 2673 例行根治性手术的 GC 患者。在这 2673 例 GC 患者中,1979 例(74.0%)为男性。经过倾向评分匹配后,共纳入 846 例患者进行分析,其中男性 423 例,女性 423 例。两组间的临床病理特征无显著差异。在初始复发模式方面,男性比女性更容易发生肿瘤复发和肝转移,尤其是在 III 期 GC 中。在分子分析方面,男性的表达水平高于女性,尤其是在 III 期 GC 中。此外,年龄≥65 岁的患者较年龄<65 岁的患者有更高的表达水平。多因素分析表明,性别是影响总生存(OS)和无病生存(DFS)的独立预后因素之一。在发生肝转移的患者中,年龄较大的男性患者中更常见 表达。男性比女性更易发生肿瘤复发和更高的表达水平,尤其是在 III 期 GC 中。对于发生肝转移的 GC 患者,建议进行 检测,尤其是在年龄较大的男性患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/7835020/b334b772e513/aging-13-202142-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/7835020/20833ed38244/aging-13-202142-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/7835020/b334b772e513/aging-13-202142-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/7835020/20833ed38244/aging-13-202142-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d833/7835020/b334b772e513/aging-13-202142-g002.jpg

相似文献

1
Genetic alterations in gastric cancer patients according to sex.胃癌患者的性别相关基因改变。
Aging (Albany NY). 2020 Dec 3;13(1):376-388. doi: 10.18632/aging.202142.
2
Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.胃癌患者靶向治疗标志物的表达谱:HER-2、微卫星不稳定性和 PD-L1。
Mol Diagn Ther. 2019 Dec;23(6):761-771. doi: 10.1007/s40291-019-00424-y.
3
Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.胃癌中爱泼斯坦-巴尔病毒感染、微卫星不稳定性及程序性死亡受体配体1表达的临床病理特征和预后特征
J Surg Oncol. 2018 Apr;117(5):829-839. doi: 10.1002/jso.25022. Epub 2018 Mar 13.
4
The clinicopathological characteristics and genetic alterations of mucinous carcinoma of the stomach.胃黏液腺癌的临床病理特征及基因改变。
J Chin Med Assoc. 2020 Feb;83(2):141-147. doi: 10.1097/JCMA.0000000000000232.
5
Prognostic significance of microsatellite instability in patients with resectable gastric cancer.可切除胃癌患者中微卫星不稳定性的预后意义。
J Gastrointest Surg. 2024 Oct;28(10):1687-1695. doi: 10.1016/j.gassur.2024.07.019. Epub 2024 Aug 14.
6
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer.双免疫组化染色检测程序性死亡配体-1 表达的联合阳性评分和肿瘤比例评分对晚期胃癌患者预后的影响。
Gastric Cancer. 2020 Jan;23(1):95-104. doi: 10.1007/s10120-019-00999-9. Epub 2019 Aug 26.
7
Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.循环中可溶性 PD-L1 表达作为胃癌复发和预后的预测标志物:组织和血清 PD-L1 表达的临床负担直接比较。
Ann Surg Oncol. 2019 Mar;26(3):876-883. doi: 10.1245/s10434-018-07112-x. Epub 2018 Dec 18.
8
Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.程序性细胞死亡配体-1在肺腺癌中的表达的临床病理及预后意义及其与p53状态的关系
Lung Cancer. 2016 Jul;97:73-80. doi: 10.1016/j.lungcan.2016.05.001. Epub 2016 May 3.
9
Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.在西方患者中,胃癌的肿瘤内异质性和 ARID1A 表达缺失与 PD-L1 表达增加相关。
Hum Pathol. 2019 Dec;94:98-109. doi: 10.1016/j.humpath.2019.09.016. Epub 2019 Nov 6.
10
AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer.AKT/mTOR 信号级联与 PD-1、PD-L1 和 PD-L2 在胃癌中的表达。
Bull Exp Biol Med. 2020 Nov;170(1):75-78. doi: 10.1007/s10517-020-05007-0. Epub 2020 Nov 24.

引用本文的文献

1
Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China.性别差异、诊断前生活方式因素与胃癌长期生存:来自中国的多中心队列研究。
BMC Cancer. 2024 Sep 16;24(1):1149. doi: 10.1186/s12885-024-12873-8.
2
Gender Differences in Patients with Gastric Adenocarcinoma.胃腺癌患者的性别差异
J Clin Med. 2024 Apr 25;13(9):2524. doi: 10.3390/jcm13092524.
3
Diffuse type gastric adenocarcinoma with atypical presentation: A case report.表现不典型的弥漫型胃腺癌:病例报告

本文引用的文献

1
Promutagenicity of 8-Chloroguanine, A Major Inflammation-Induced Halogenated DNA Lesion.8-氯鸟嘌呤的诱变原性,一种主要的炎症诱导的卤化 DNA 损伤。
Molecules. 2019 Sep 27;24(19):3507. doi: 10.3390/molecules24193507.
2
Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer.全基因组测序揭示了胃癌中新的串联重复热点和预后突变特征。
Nat Commun. 2019 May 2;10(1):2037. doi: 10.1038/s41467-019-09644-6.
3
Nanoparticle systems for cancer vaccine.用于癌症疫苗的纳米颗粒系统。
Clin Case Rep. 2024 May 7;12(5):e8849. doi: 10.1002/ccr3.8849. eCollection 2024 May.
4
Prediction model of liver metastasis risk in patients with gastric cancer: A population-based study.胃癌患者肝转移风险预测模型:基于人群的研究。
Medicine (Baltimore). 2023 Sep 29;102(39):e34702. doi: 10.1097/MD.0000000000034702.
5
Sex Disparity in Patients with Gastric Cancer: A Systematic Review and Meta-Analysis.胃癌患者的性别差异:一项系统评价与荟萃分析。
J Oncol. 2022 Nov 2;2022:1269435. doi: 10.1155/2022/1269435. eCollection 2022.
6
Clinico-radiological nomogram for preoperatively predicting post-resection hepatic metastasis in patients with gastric adenocarcinoma.用于术前预测胃腺癌患者肝转移切除术后转移的临床放射列线图。
Br J Radiol. 2022 Dec 1;95(1140):20220488. doi: 10.1259/bjr.20220488. Epub 2022 Nov 8.
7
Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients.2983 例胃癌手术患者的组织学、分期和预后的性别差异。
World J Gastroenterol. 2022 Mar 7;28(9):933-947. doi: 10.3748/wjg.v28.i9.933.
8
Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma.核仁蛋白 NOP2 可作为透明细胞肾细胞癌的潜在预后预测因子。
Bioengineered. 2021 Dec;12(1):4841-4855. doi: 10.1080/21655979.2021.1960130.
9
CACNA1C is a prognostic predictor for patients with ovarian cancer.CACNA1C 是卵巢癌患者的预后预测因子。
J Ovarian Res. 2021 Jul 1;14(1):88. doi: 10.1186/s13048-021-00830-z.
Nanomedicine (Lond). 2019 Mar;14(5):627-648. doi: 10.2217/nnm-2018-0147. Epub 2019 Feb 26.
4
Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without Infection.比较有和没有感染的胃癌患者的临床病理特征和基因改变。
Oncologist. 2019 Sep;24(9):e845-e853. doi: 10.1634/theoncologist.2018-0742. Epub 2019 Feb 22.
5
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
6
FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1.FDA 批准概要:帕博利珠单抗用于表达 PD-L1 的复发性局部晚期或转移性胃或胃食管连接部腺癌。
Oncologist. 2019 Jan;24(1):103-109. doi: 10.1634/theoncologist.2018-0221. Epub 2018 Aug 17.
7
Sex disparity in cancer: roles of microRNAs and related functional players.癌症中的性别差异:miRNAs 及相关功能因子的作用
Cell Death Differ. 2018 Mar;25(3):477-485. doi: 10.1038/s41418-017-0051-x. Epub 2018 Jan 19.
8
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.胃癌中微卫星不稳定性与临床病理特征及总生存关系的荟萃分析。
Br J Surg. 2018 Feb;105(3):159-167. doi: 10.1002/bjs.10663. Epub 2017 Nov 1.
9
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.用于癌症免疫治疗的PD-1和PD-L1检查点信号抑制:机制、联合应用及临床结果
Front Pharmacol. 2017 Aug 23;8:561. doi: 10.3389/fphar.2017.00561. eCollection 2017.
10
The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.PD-L1 表达在胃癌中的临床病理和预后意义:10 项研究、1901 例患者的荟萃分析。
Sci Rep. 2016 Nov 28;6:37933. doi: 10.1038/srep37933.